Shalaurova; Irina Y.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shalaurova; Irina Y..The latest application filed is for "cardiovascular risk evaluations using a risk parameter that includes an hdl and inflammatory biomarker interaction parameter".

Company Profile

5.14.19

Shalaurova; Irina Y. - Cary NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cardiovascular Risk Evaluations Using a Risk Parameter That Includes an HDL and Inflammatory Biomarker Interaction Parameter App 20220137076 - Otvos; James D. ; et al.	2022-05-05
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter Grant 11,231,429 - Otvos , et al. January 25, 2	2022-01-25
Multi-parameter metabolic vulnerability index evaluations Grant 11,156,621 - Otvos , et al. October 26, 2	2021-10-26
Multiple-Marker Risk Parameters Predictive of Conversion to Diabetes App 20210304898 - Otvos; James D. ; et al.	2021-09-30
Multiple-marker risk parameters predictive of conversion to diabetes Grant 11,037,683 - Otvos , et al. June 15, 2	2021-06-15
NMR Measurements of NMR Biomarker GlycA App 20210080452 - Otvos; James D. ; et al.	2021-03-18
NMR measurements of NMR biomarker GlycA Grant 10,852,293 - Otvos , et al. December 1, 2	2020-12-01
Multi-Parameter Diabetes Risk Evaluations App 20200005943 - Otvos; James D. ; et al.	2020-01-02
CHD Risk Stratification Evaluations for Subjects With High Levels of Large HDL-P App 20200003752 - Otvos; James D. ; et al.	2020-01-02
Multi-parameter diabetes risk evaluations Grant 10,388,414 - Otvos , et al. A	2019-08-20
CHD risk stratification evaluations for subjects with high levels of large HDL-P Grant 10,386,355 - Otvos , et al. A	2019-08-20
Multi-Parameter Metabolic Vulnerability Index Evaluations App 20190072572 - Otvos; James D. ; et al.	2019-03-07
Cardiovascular Risk Evaluations Using a Risk Parameter that Includes an HDL and Inflammatory Biomarker Interaction Parameter App 20180196075 - Otvos; James D. ; et al.	2018-07-12
Multiple-Marker Risk Parameters Predictive of Conversion to Diabetes App 20180158554 - Otvos; James D. ; et al.	2018-06-07
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter Grant 9,952,232 - Otvos , et al. April 24, 2	2018-04-24
Multiple-marker risk parameters predictive of conversion to diabetes Grant 9,928,345 - Otvos , et al. March 27, 2	2018-03-27
Multi-parameter diabetes risk evaluations Grant 9,792,410 - Otvos , et al. October 17, 2	2017-10-17
CHD Risk Stratification Evaluations for Subjects with High Levels of Large HDL-P App 20170017772 - OTVOS; JAMES D. ; et al.	2017-01-19
NMR Measurements of NMR Biomarker GlycA App 20170003269 - Otvos; James D. ; et al.	2017-01-05
Multi-Parameter Diabetes Risk Evaluations App 20160321424 - Otvos; James D. ; et al.	2016-11-03
Protective HDL particle number evaluations Grant 9,483,611 - Otvos , et al. November 1, 2	2016-11-01
CHD risk stratification evaluations for subjects with high levels of large HDL-P Grant 9,483,612 - Otvos , et al. November 1, 2	2016-11-01
NMR measurements of NMR biomarker GlycA Grant 9,470,771 - Otvos , et al. October 18, 2	2016-10-18
Multi-parameter diabetes risk evaluations Grant 9,361,429 - Otvos , et al. June 7, 2	2016-06-07
Cardiovascular Risk Evaluations Using A Risk Parameter That Includes An Hdl And Inflammatory Biomarker Interaction Parameter App 20160077116 - Otvos; James D. ; et al.	2016-03-17
Multi-parameter Diabetes Risk Evaluations App 20150149095 - Otvos; James D. ; et al.	2015-05-28
Multiple-marker Risk Parameters Predictive Of Conversion To Diabetes App 20150127267 - Otvos; James D. ; et al.	2015-05-07
Nmr Measurements Of Glyca App 20130328561 - Otvos; James D. ; et al.	2013-12-12
Multi-parameter Diabetes Risk Evaluations App 20130332082 - Otvos; James D. ; et al.	2013-12-12
Chd Risk Stratification Evaluations For Subjects With High Levels Of Large Hdl -p App 20130289885 - Otvos; James D. ; et al.	2013-10-31
Protective Hdl Particle Number Evaluations App 20130289884 - Otvos; James D. ; et al.	2013-10-31
Method of determining presence and concentration of lipoprotein X in blood plasma and serum Grant 6,617,167 - Otvos , et al. September 9, 2	2003-09-09
Method of determining presence and concentration of lipoprotein X in blood plasma and serum App 20030054559 - Otvos, James D. ; et al.	2003-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.